Twenty thirteen was a pivotal year for the MPP. The organisation strengthened its relationships with key stakeholders including communities living with HIV, international organisations, governments, civil society and industry to move forward key initiatives to increase access to HIV medicines in developing countries. Last year, the MPP signed three public health-focused agreements with ViiV Healthcare, Bristol-Myers Squibb and F. Hoffmann-La Roche. We also stepped up our work with generic manufacturers and are now managing more than two dozen sub-licensing projects with six companies.
Learn more about our work and our 2013 achievements: download the 2013 annual report (PDF)